Recent Updates
Recently added Catalysts
CHRS Positive Sentiment Score: 70/100

Coherus BioSciences Announces New Employment Inducement Grants

Friday, February 3, 2023 1 min read
Key Takeaway: Coherus BioSciences has announced the granting of stock options to three newly hired employees as part of its ongoing efforts to enhance its workforce. The options, totaling 22,500 shares at an exercise price of $8.65 per share, were granted on February 1, 2023. This move is part of the Company’s 2016 Employment Commencement Incentive Plan aimed at attracting talent to the organization. The initiative demonstrates Coherus' commitment to investing in its human resources as it navigates the biopharmaceutical landscape.

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus BioSciences expands its team with new hires.
  • The stock options are an attractive incentive for new employees.
  • The grants align with the company's strategy to boost its workforce.

Full Press Release Details

REDWOOD CITY, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective February 1, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 22,500 shares of the common stock of the Company to three newly hired employees with a per share exercise price of $8.65, the closing trading price on the grant date.
The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.
Coherus BioSciences Contact Information:
Coherus BioSciences, Inc.

Frequently Asked Questions

What company granted stock options on February 1, 2023?

Coherus BioSciences, Inc. granted stock options on February 1, 2023.

How many shares were granted as stock options?

An aggregate of 22,500 shares were granted as stock options.

What was the exercise price for the stock options?

The exercise price for the stock options was $8.65 per share.

What plan governs the stock options granted?

The stock options were granted under the 2016 Employment Commencement Incentive Plan.

Who were the stock options granted to?

The options were granted to three newly hired employees.

Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences employment grants stock options biopharmaceuticals
Last updated: Feb 3, 2023